Day zero of autologous cryopreserved hematopoietic stem cell transplantation: microcosting of care provided by senior nurses.
Valéria Aparecida Gomes Nunes, Antônio Fernandes Costa Lima
PMID 41838861WHAT IT FOUND
Day-zero nursing care for autologous cryopreserved stem cell transplant averaged US$739.81.
The stem cell bag infusion cost US$631.62, and nurse time dominated cost in most procedures.
Key findings
01The average direct cost of senior-nurse care on day zero was US$739.81, with 8.04% in pre-HSCT, 89.68% in intra-HSCT and 2.28% in post-HSCT phases.
02The stem cell bag infusion was the highest intra-infusion procedure cost at US$631.62, with US$628.36 from supplies.
03Nurse labor time was the largest cost component in 90.90% of pre-infusion procedures and 85.71% of post-infusion procedures.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was done at a single public transplant hospital in São Paulo, so its costs may not apply to other services. Sampling was intentional and non-probabilistic, and it observed 16 patients and 28 senior nurses. It covered only day-zero care for autologous cryopreserved HSCT, not other transplant types or infusion modalities. It measured senior-nurse direct costs only, not the full cost of transplant or patient outcomes. One author was the Nursing Supervisor at the study hospital and collected the data.
Declared interests
One author was the Nursing Supervisor at the study hospital and collected the data. The supplied text does not state who funded the work or declare other conflicts of interest.
The easy way to misread this
Do not read this as evidence that these nursing procedures improve transplant outcomes or reduce complications. It describes costs and time only, in one unit, and does not test whether changing them makes patients safer.